Adequate renal, bone marrow, hepatic, pulmonary, and cardiac function
Adequate bone marrow, renal, and liver function
Has adequate bone marrow, renal and hepatic function based upon laboratory tests as follows:
Participant has adequate bone marrow, renal, and hepatic function.
Adequate bone-marrow, renal and liver function.
Participants have adequate bone marrow, renal, hepatic and coagulation function.
Adequate hepatic, renal, and bone marrow function:
Adequate Bone Marrow, Renal, and Liver Function.
Must have adequate bone marrow, liver, and renal function as described in protocol
Patients must have adequate bone marrow, hepatic and renal function as defined below:
Adequate bone marrow function, hepatic function, and renal function
Participant has adequate bone marrow, renal and hepatic function.
Severe bone marrow, renal or liver impairment.
Adequate Bone Marrow, Liver, Renal, Pancreatic Function
Adequate bone marrow, renal, hepatic, and metabolic function (assessed ? 7 days before inclusion in the study):
Adequate bone marrow, liver, renal, and cardiac function at study entry, assessed as follows:
Adequate bone marrow, renal and liver function
Adequate bone marrow reserve, liver and renal function
Adequate bone marrow, liver, and renal function.
Adequate bone marrow, liver, and renal function
Adequate bone marrow, renal, and liver function
Adequate bone marrow, liver and renal function
Adequate bone marrow, renal and liver function.
Must have adequate bone marrow, renal, and hepatic function (For the sub-study, the subject must have adequate bone marrow and renal function and have mild-to-moderate hepatic impairment)
Adequate bone marrow (BM), renal, hepatic and metabolic function.
Adequate bone marrow reserve, cardiac, liver, renal and metabolic function:
Adequate marrow, liver, and renal function:
Patients must have adequate bone marrow, liver, coagulation and renal function within 7 days prior to study registration, as defined below:
Adequate bone marrow, renal, hepatic, pulmonary, and cardiac function
Participants have adequate bone marrow, renal, hepatic and coagulation function.
Bone marrow, hepatic, and renal function as follows:
Hepatic function, renal function, bone marrow function in defined lab-value-ranges
Subject has adequate bone marrow, renal, and hepatic function.
Adequate bone marrow, renal, hepatic, pulmonary, and cardiac function defined as:
Adequate bone marrow reserves, hepatic function, and renal function
Adequate bone marrow, liver, renal and coagulation function
Must have adequate bone marrow and renal/hepatic function at the screening and baseline visits, defined as:
Adequate bone marrow, renal and liver function.
Adequate renal, liver and bone marrow function:
Adequate bone marrow, hepatic, and renal function
Adequate bone marrow, hepatic, and renal function, as specified in the protocol
Participants must have adequate bone marrow, hepatic and renal function
Adequate bone marrow, hepatic, and renal function, as specified in the protocol
Adequate bone marrow (BM), renal, hepatic and metabolic function;
Adequate bone marrow, renal and liver function.
Participant has adequate bone marrow, renal, and hepatic function.
Adequate bone marrow, liver and renal function.
Adequate bone marrow, hepatic, and renal function
Adequate bone marrow, renal and hepatic function:
Patient has adequate bone marrow, coagulation, liver and renal function
Adequate Bone Marrow, Pancreatic Function, Renal Function and Liver Function.
Participant must have adequate bone marrow, renal, and hepatic function.
Adequate renal, liver, and bone marrow function according to the following criteria:
Adequate liver, bone marrow and renal function
Subject has adequate bone marrow, renal, hepatic and coagulation function.
Adequate bone marrow (BM), renal, hepatic, and metabolic function (assessed ? 14 days before inclusion in the study):
Subjects must have adequate bone marrow, renal and hepatic function and coagulation
Adequate hepatic, renal and bone marrow function.
Adequate bone marrow, renal, liver and pancreatic function
Participants must have adequate bone marrow, renal and hepatic function
Adequate bone marrow, liver and renal function
Adequate bone marrow, liver and renal function
Adequate bone marrow, renal, and liver function.
Acceptable bone marrow, renal, and hepatic function based upon screening lab tests
Adequate bone marrow, liver and renal function renal function
Subject must have adequate bone marrow, renal and hepatic function.
Adequate bone marrow, hepatic, renal and cardiac function
Adequate hepatic, renal, and bone marrow function
Patients with adequate bone marrow, renal and hepatic function:
Adequate bone marrow reserve, hepatic and renal function
Adequate bone marrow, renal and liver function.
Adequate bone marrow, liver and renal function
Adequate bone marrow, renal, and hepatic function.
Adequate bone marrow, liver and renal function
Adequate renal, hepatic, and bone marrow function demonstrated by protocol-specified laboratory parameters at the screening visit.
Adequate bone marrow, hepatic and renal function as evidenced by:
Adequate bone marrow, renal, liver, cardiac and pulmonary function.
Adequate bone marrow, liver and renal function
Adequate bone marrow, renal capacity and hepatic function
Adequate bone marrow, liver and renal function
Adequate bone marrow, liver, and renal function
Patients must have adequate bone marrow function (ANC >/= 1,500/mm3 and platelet count of >/= 100,000/mm3), adequate liver function (SGPT and serum glutamate oxaloacetate transaminase (SGOT) </= 2.5 times normal, bilirubin </= 2 mg/dl), and adequate renal function (BUN and creatinine </=1.5 times institutional normal) prior to starting therapy.
Adequate bone marrow, liver, cardiac, and renal function
Adequate bone marrow, renal, hepatic, and metabolic function
Impaired bone marrow, liver or renal function (as defined by protocol)
Adequate bone marrow, hepatic, and renal function tests within 30 days prior to enrollment:
Subject has adequate bone marrow, renal and hepatic function at baseline, as demonstrated by the following:
Adequate bone marrow, renal and liver functioning
Adequate bone marrow and renal function
Adequate bone marrow, renal and liver function
Planned biopsy or resection of recurrent tumor for therapeutic and/or diagnostic purpose, and with adequate bone marrow, hepatic, cardiac, and renal function to undergo this planned procedure
Adequate bone marrow, hepatic and renal function as evidenced by:
Protocol-defined renal , liver and bone marrow function
Adequate bone marrow, hepatic, renal and cardiac function
Adequate bone marrow, liver, and renal function
Adequate bone marrow, renal and liver function as defined in the protocol.
The participant has adequate bone marrow reserve, and renal and hepatic function
Adequate bone marrow, liver and renal function
Participant has adequate bone marrow, renal, hepatic and cardiac function.
Adequate bone marrow, renal, and hepatic function.
Adequate bone marrow, liver, cardiac, and renal function
Adequate bone marrow, liver, and renal function
Patients must have adequate bone marrow, renal, hepatic, and sensory neurologic function to be eligible to receive platinum/taxane-based chemotherapy
Adequate bone marrow, liver and renal function
Adequate bone marrow, renal, hepatic, and blood clotting function
Adequate bone marrow, renal, hepatic, and metabolic function (assessed ? 7 days before inclusion in the study):
Adequate bone marrow, liver, and renal function
